Form D · Biotechnology
ALT Bioscience LLC
Lexington, KY · CIK 0001424900
Offering snapshot reported Jun 26, 2015 · SEC filing
- Reported sold
- $6.38M Offering amount: $6.8M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $10.4K Reported outside-investor minimum
- First sale
- Feb 22, 2013 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,446,072 → $6,377,770
- Reported investors24 → 42
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2015 | Amendment | $6,377,770 | $4,931,698vs Jan 16, 2014 | 42 | SEC filing |
| Jan 16, 2014 | Initial | $1,446,072 | No comparison | 24 | SEC filing |
| Mar 28, 2011 | Initial | $1,699,999 | No comparison | 28 | SEC filing |
| Sep 20, 2010 | Initial | $920,190 | No comparison | 27 | SEC filing |
| Mar 8, 2010 | Initial | $1,079,815 | No comparison | 19 | SEC filing |
| Nov 13, 2009 | Initial | $853,501 | No comparison | 18 | SEC filing |
| Jan 9, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $60K (estimated)
- Form D file number
- 021-210269
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Brutus Clay | None |
Source: Form D, filed Jun 26, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tony Burgess Cassler | Executive |
| Angela Chapman | Executive |
| Leslie Herzog | Executive |
| Maureen Leesman | Executive |
| Maureen Lessman | Executive |
| David Mc Clure | Executive |
| Russell Secter | Executive |
| Tami Shell | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
315 South Broadway Suite 100
Lexington, KY, 40508
Lexington, KY, 40508